Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk: Molecular Therapy - Methods & Clinical Development
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease | Translational Psychiatry
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline | Alzheimer's Research & Therapy | Full Text
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
JCM | Free Full-Text | Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
The complex pathway between amyloid β and cognition: implications for therapy - The Lancet Neurology
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Decreased salivary lactoferrin levels are specific to Alzheimer's disease - eBioMedicine
Identifying and validating biomarkers for Alzheimer's disease: Trends in Biotechnology
JPM | Free Full-Text | Current Biomarkers for Alzheimer's Disease: From CSF to Blood
Frontiers | Alzheimer's disease: a mini-review for the clinician
Blood‐based biomarkers for Alzheimer's disease | EMBO Molecular Medicine
ADPD 2023: Alzheimer's Disease Therapeutics, Diagnostics & Mechanisms
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy
Cells | Free Full-Text | Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
New Alzheimer's Biomarkers may Support Early Diagnosis
Frontiers | Manipulation of the diet–microbiota–brain axis in Alzheimer's disease
JPM | Free Full-Text | Biomarkers for Alzheimer's Disease Early Diagnosis
Mechanisms of action of anti-Aβ-antibodies. Anti-Aβ-antibodies can... | Download Scientific Diagram
